Trial Profile
Multicentral phase II study which verifies the completion rate of adjuvant S-1 chemotherapy in elderly patients with gastric cancer.
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 11 Nov 2013
Price :
$35
*
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary)
- Indications Gastric cancer
- Focus Adverse reactions
- 11 Nov 2013 New trial record